Boston Scientific: Healthy Growth – Analyst Blog
Source: http://www.zacks.com/stock/news/18258/Boston+Scientific%3A+Healthy+Growth+-+Analyst+BlogPosted on Tuesday, March 17th, 2009 | In Stocks to Watch
Boston Scientific Corp. (BSX) competes in the cardiovascular, endosurgery and neuromodulation markets. All 3 segments are experiencing strong sales growth and should remain relatively insulated from the current economic crisis.
BSX has historically grown through acquisition, which has led to earnings-quality concerns. Recent positive news on stents will bode well. Trial results for Abbott Labs’ (ABT) XIENCE stent, which BSX markets under a private label, were positive. And, BSX received U.S. approval to market its TAXUS Liberte and Express2 stents.
BSX reported Q408 and FY08 results in-line with management guidance. Several new products are expected to be launched in 2009, and we expect a rebound in the stock this year. Thus, we reiterate our Buy rating.
Rajarshi Maulik contributed to this report.
Read the full analyst report on “BSX”
Read the full analyst report on “ABT”
Zacks Investment Research
Last 5 posts by Zacks Market Commentaries
- VIP Falls Behind Expectations - Analyst Blog - November 25th, 2009
- J. Crew Beats Zacks Estimates - Analyst Blog - November 25th, 2009
- No Change in Deere's Outlook - Analyst Blog - November 25th, 2009
- Sprint Acquires Virgin Mobile USA - Analyst Blog - November 25th, 2009
- Provenge Action Date Assigned - Analyst Blog - November 25th, 2009
Abbott Labs, Blog, Boston Scientific Corp.;, BSX;, Express2;, Stocks to Watch, United States, Zacks Market Commentaries
 About Zacks Market Commentaries (http://www.zacks.com/)
Zacks Market Commentaries |
No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.